AVX
Click for more information
0.00% 2.5¢ avexa limited

Apricitabine may have been "perhaps the top clinical jewel in...

  1. mw03
    2,136 Posts.
    lightbulb Created with Sketch. 61
    clock Created with Sketch.
    14/11/09
    14:27
    Post #: 5913895
    Apricitabine may have been "perhaps the top clinical jewel in the Australian biotech industry" last year, but CXS's Omacetaxine or BTA's Relenza+Laninamivir will probably win it this year. Maybe next year it will regain top place.


    Mal
    AVX Price at posting: 19.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
CXO Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
NEWS Good debt vs bad debt for the property in your investment portfolio
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AVX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.